Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: ADAPTIVE BIOTECHNOLOGIES CORPORATION
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-01-18 to 2024-01-17
Current total value of award: $46015
Description: ADAPTIVE BIOTECHNOLOGIES CORPORATION - 119 QTY IMMUNOSEQUENCING  (AMBIS 2148396)